Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19
NCT04443725
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Hydroxychloroquine , Sofosbuvir, daclatasvir
DRUG:
Standard of care treatment
Sponsor
Cairo University